Life Biosciences receives FDA clearance for the first human trial of cellular reprogramming targeting glaucoma and NAION, signaling regulatory openness to longevity therapies and potential vision rest...
Emerging senolytic treatments target cellular senescence to reduce inflammation and improve kidney function in diabetic patients, with recent clinical trials confirming safety and hinting at efficacy....
Recent studies show FMT from young donors improves gut health and cognitive function in aging, with FDA updates and probiotic innovations paving the way for scalable therapies. New research reveals FM...
Recent research indicates shingles vaccination may reduce inflammation and epigenetic aging in older adults, potentially lowering risks of dementia and cardiovascular diseases. Emerging evidence shows...
Recent studies show that regular exercise combats immunosenescence by boosting immune cell activity, reducing inflammation, and improving metabolic health in older adults. New research highlights exer...
Analysis of metabolites like taurine and NAD+ in aging research, highlighting animal studies, human trials, and ethical considerations for longevity strategies. Emerging research on metabolites reveal...
Recent studies reveal that age-related proteasomal decline activates the cGAS-STING pathway through mitochondrial DNA leakage, fueling chronic inflammation linked to Alzheimer’s, with exercise a...
Recent studies reveal transcription factors AP1 and KLF5 drive T cell senescence, with new epigenetic interventions offering hope for enhancing immune function in the elderly. Cutting-edge research un...
Biotech advancements in thymus regeneration, like TECregen’s therapies, show promise in rejuvenating immune function for aging populations, addressing delivery challenges and ethical considerati...
Stanford Medicine study finds inhibiting 15-PGDH enzyme regenerates cartilage in aged mice, offering a non-invasive osteoarthritis treatment that could reduce joint replacements and improve life quali...
